Tesamorelin · source year
3 selected, source-linked Tesamorelin records carrying a 2018 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
3 selected records.
1 represented type.
3 distinct public records.
Cited chronology
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 21695284 at 2026-07-30T21:09:11.482Z. PubMed recorded a metadata revision date of 2018-12-01 and an Entrez history date of 2011-06-23. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 25895899 at 2026-07-30T21:09:16.102Z. PubMed recorded a metadata revision date of 2018-11-13 and an Entrez history date of 2015-04-22. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 28832410 at 2026-07-30T21:09:26.816Z. PubMed recorded a metadata revision date of 2018-11-13 and an Entrez history date of 2017-08-24. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗